Last Posted: Feb 06, 2020
- Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.
Rodríguez-Borjabad Cèlia et al. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2020 Jan - Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application.
Pang Jing et al. Heart, lung & circulation 2019 Dec - Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname Marcio H et al. Progress in cardiovascular diseases 62(5) 414-422 - A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia.
Di Taranto Maria Donata et al. Journal of clinical medicine 2020 Jan 9(1) - FH as a Prototype for Precision Public Health
The FH Foundation, 2019 FH Global summit, day 2 highlights, January 2020 - Reducing the Global Public Health Burden of Familial Hypercholesterolemia: More Work Ahead
MJ Khoury et al, CDC Blog, January 21 2020 - 2019 FH Global Summit Presentation Slides
The FH Foundation, January 2020 - Public Policy Recs Updated for Familial Hypercholesterolemia- Goals include enhancing awareness of familial hypercholesterolemia as a global public health issue
Health day, January 2020 - Mayo genomic database to use sequencing for 100K participants
G Slabodkin, Health Data Management, January 10, 2020 - Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil.
Harada Paulo H et al. Atherosclerosis 2018 277273-277
.jpeg)
No hay comentarios:
Publicar un comentario